Fineline Cube

Follow:
14778 Articles
uBriGene Secures RMB 200 Million in Pre-Series D Financing to Expand ATMPs CDMO Services
CompanyDeals

uBriGene Secures RMB 200 Million in Pre-Series D Financing to Expand ATMPs CDMO Services

WuXi AppTec to Divest WuXi Advanced Therapies and Oxford Genetics to Altaris LLC
CompanyDeals

WuXi AppTec to Divest WuXi Advanced Therapies and Oxford Genetics to Altaris LLC

Basecare Medical and SolarCare Form Alliance to Advance AI in IVF Services
CompanyDeals

Basecare Medical and SolarCare Form Alliance to Advance AI in IVF Services

Alphamab Oncology's JSKN033 Gets Green Light for Phase I/II Study from China's CDE
CompanyDrug

Alphamab Oncology’s JSKN033 Gets Green Light for Phase I/II Study from China’s CDE

CSPC Pharmaceutical's SYH2062 Receives NMPA Clearance for Hypertension Treatment
CompanyDrug

CSPC Pharmaceutical’s SYH2062 Receives NMPA Clearance for Hypertension Treatment

Keymed Biosciences' Kangyueda Approved for CRSwNP Treatment in China
CompanyDrug

Keymed Biosciences’ Kangyueda Approved for CRSwNP Treatment in China

Sichuan Biokin's GNC-038 Tetra-Specific Antibody Clears for Clinical Trials in Autoimmune Diseases
CompanyDrug

Sichuan Biokin’s GNC-038 Tetra-Specific Antibody Clears for Clinical Trials in Autoimmune Diseases

Changchun High & New Technology Industries Receives FDA Approval for Menopausal VMS Drug Trial
CompanyDrug

Changchun High & New Technology Industries Receives FDA Approval for Menopausal VMS Drug Trial

AstraZeneca's Tagrisso Secures EU Approval for EGFR-Mutated Locally Advanced NSCLC
CompanyDrug

AstraZeneca’s Tagrisso Secures EU Approval for EGFR-Mutated Locally Advanced NSCLC

Ikena Oncology and Inmagene Biopharmaceuticals to Merge into ImageneBio, Listed on Nasdaq as 'IMA'
CompanyDeals

Ikena Oncology and Inmagene Biopharmaceuticals to Merge into ImageneBio, Listed on Nasdaq as ‘IMA’

Sanofi and SK bioscience Broaden Partnership to Develop Next-Gen Pneumococcal Vaccines
CompanyDeals

Sanofi and SK bioscience Broaden Partnership to Develop Next-Gen Pneumococcal Vaccines

Corxel Pharmaceuticals Secures Global Rights to CX11, a Novel Oral GLP-1 RA, in Licensing Deal with Vincentage
CompanyDeals

Corxel Pharmaceuticals Secures Global Rights to CX11, a Novel Oral GLP-1 RA, in Licensing Deal with Vincentage